NCT06454838 Exercise Capacity Muscle Oxygenation and Arterial Stiffness in Children With Pulmonary Arterial Hypertension
| NCT ID | NCT06454838 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Gazi University |
| Condition | Pulmonary Arterial Hypertension |
| Study Type | OBSERVATIONAL |
| Enrollment | 26 participants |
| Start Date | 2024-04-30 |
| Primary Completion | 2025-08-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 26 participants in total. It began in 2024-04-30 with a primary completion date of 2025-08-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary aim is to evaluate pulmonary function, respiratory muscle strength, upper and lower extremity exercise capacity, muscle oxygenation, dyspnea, peripheral muscle strength, arterial stiffness, physical activity level and balance in children with pulmonary arterial hypertension and compare with age- and sex-matched healthy controls. The second aim is to investigate the relationship between upper extremity exercise capacity, arterial stiffness, respiratory and peripheral muscle strength
Eligibility Criteria
Inclusion Criteria: Patients: * Between the ages of 6-18 * Diagnosed with pulmonary arterial hypertension * Stability of clinical condition and receiving standard medical treatment Healthy controls: * Between the ages of 6-18 * Willing to participate in the study Exclusion Criteria: Patients: * Having any acute infection, orthopedic, neurological, cooperation, vision or hearing problems that may prevent during the measurements * Participated in a planned exercise program in a last three months Healthy controls: * Having any acute or chronic illness * Active or ex-smoker
Contact & Investigator
Meral BOŞNAK GÜÇLÜ, Prof. Dr.
STUDY DIRECTOR
Gazi University
Frequently Asked Questions
Who can join the NCT06454838 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, up to 18 Years, studying Pulmonary Arterial Hypertension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06454838 currently recruiting?
Yes, NCT06454838 is actively recruiting participants. Contact the research team at meralbosnak@gazi.edu.tr for enrollment information.
Where is the NCT06454838 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT06454838 clinical trial?
NCT06454838 is sponsored by Gazi University. The principal investigator is Meral BOŞNAK GÜÇLÜ, Prof. Dr. at Gazi University. The trial plans to enroll 26 participants.